Is there a role for estrogen in the prevention and treatment of urinary incontinence?

Holroyd-Leduc, Jayna M.; Straus, Sharon E.
April 2005
CMAJ: Canadian Medical Association Journal;4/12/2005, Vol. 172 Issue 8, p1003
Academic Journal
Deals with a study which aimed to determine the role of estrogen in the treatment of urinary incontinence. Subject used in the study; Result and commentary.


Related Articles

  • Hormone Therapy for Postmenopausal Women with Urinary Incontinence. LEE, JAY H.; GOMEZ, SUZANNE; JANKOWSKI, TERRY ANN // American Family Physician;7/1/2011, Vol. 84 Issue 1, following p20 

    The article discusses whether hormone therapy improve urinary incontinence in postmenopausal women (PMW). The authors report that PMW should not receive oral hormone therapy for treatment of urinary incontinence. They say that in a 2009 Cochrane review of 33 trials including 19,313 women with...

  • Hormone therapy increased incidence and severity of urinary incontinence in healthy postmenopausal women: Commentary.. Atkins, David // Evidence Based Medicine;Aug2005, Vol. 10 Issue 4, p121 

    Discusses the role of hormone therapy in treating urinary incontinence (UI) among healthy postmenopausal women. Benefits of oestrogen on genital symptoms; Effects of oestrogen and progestin on UI; Recommendations on drug dosage for the treatment of the disease.

  • Urinary incontinence secondary to severe labial agglutination. Michael Flynn; Gunhilde Buchsbaum // International Urogynecology Journal;Feb2008, Vol. 19 Issue 2, p253 

    Abstract  The purpose of the study was to describe the presentation and management of urinary incontinence because of severe labial adhesions. Records of all patients diagnosed with labial agglutination and urinary incontinence at the Division of Gynecologic Specialties between...

  • Turner Syndrome: Transition from Pediatrics to Adulthood.  // Endocrine Practice;Sep2008, Vol. 14 Issue 6, p775 

    Objective: To highlight the importance of an improved, seamless, and effective transition from pediatric to adult care, especially for medically complex conditions such as Turner syndrome (TS).Methods: The morbidities in adult patients with TS are reviewed, including features of the metabolic...

  • Effects of Hormone Therapy on Urinary Incontinence. Walling, Anne D. // American Family Physician;12/15/2004, Vol. 70 Issue 12, p2369 

    Discusses research being done on the effects of hormone therapy on urinary incontinence. Reference to a study by F. Grodstein et al published in the February 2004 issue of "Obstetrics and Gynecology"; Number of women participating in the Nurses' Health Study; Age-adjusted relative risk of...

  • Inhibition of neointima formation by local delivery of estrogen receptor alpha and beta specific agonists. Krom, Yvonne D.; Pires, Nuno M.M.; Jukema, J. Wouter; de Vries, Margreet R.; Frants, Rune R.; Havekes, Louis M.; van Dijk, Ko Willems; Quax, Paul H.A. // Cardiovascular Research;Jan2007, Vol. 73 Issue 1, p217 

    Abstract: Objective: Neointima formation is the underlying mechanism of (in-stent) restenosis. 17�-Estradiol (E2) is known to inhibit injury-induced neointima formation and post-angioplasty restenosis. Estrogen receptor alpha (ERa) has been demonstrated to mediate E2 anti-restenotic...

  • Developmental Changes in Testicular Sensitivity to Estrogens throughout Fetal and Neonatal Life. Géraldine Delbès; Clotilde Duquenne; Jessica Szenker; Julie Taccoen; René Habert; Christine Levacher // Toxicological Sciences;Sep2007, Vol. 99 Issue 1, p234 

    There is now compelling evidence that inappropriate exposure to estrogen during fetal or neonatal life could affect adult reproductive functions because the testis is sensitive to estrogens during specific periods of its development. Therefore, we investigated the effects of exogenous estrogens...

  • Raloxifene and Desmethylarzoxifene Block Estrogen-Induced Malignant Transformation of Human Breast Epithelial Cells. Kastrati, Irida; Edirisinghe, Praneeth D.; Hemachandra, L-P-Madhubani P.; Chandrasena, Esala R.; Choi, Jaewoo; Yue-Ting Wang; Bolton, Judy L.; Thatcher, Gregory R. J. // PLoS ONE;2011, Vol. 6 Issue 11, p1 

    There is association between exposure to estrogens and the development and progression of hormone-dependent gynecological cancers. Chemical carcinogenesis by catechol estrogens derived from oxidative metabolism is thought to contribute to breast cancer, yet exact mechanisms remain elusive....

  • Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells. Si-Min Zheng; Boon-Huat Bay; Swee-Eng Aw; Valerie C-L Lin // Breast Cancer Research & Treatment;Jul2008, Vol. 110 Issue 1, p111 

    Abstract  Over half of breast cancer cases are estrogen-dependent and strategies to combat estrogen-dependent breast cancer have been to either block the activation of estrogen receptor (ER) or diminish the supply of estrogens. Our previous work documented that estrogen-independent...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics